Literature DB >> 32157720

Cross talk between oxidative stress and hypoxia via thioredoxin and HIF-2α drives metastasis of hepatocellular carcinoma.

Man-Qing Cao1,2, A-Bin You3, Wei Cui4, Su Zhang1, Zhi-Gui Guo1, Lu Chen1, Xiao-Dong Zhu2, Wei Zhang1, Xiao-Lin Zhu1, Hua Guo1, Da-Jun Deng3, Hui-Chuan Sun2, Ti Zhang1.   

Abstract

Oxidative stress and hypoxia are two opposite microenvironments involved in HCC metastasis. Thioredoxin (TXN) and hypoxia-inducible factor 2α (HIF-2α) are typical proteins involved in these two different microenvironments, respectively. How these two factors interact to influence the fate on tumor cells remains unknown. Hypoxia facilitated HCC cells withstood oxidative stress and eventually promoted HCC cells metastasis, in which TXN and HIF-2α were mostly involved. Upregulation of TXN/HIF-2α correlated with poor HCC prognosis and promoted HCC metastasis both in vitro and in vivo. Epithelial-mesenchymal transition (EMT) process was involved in TXN/HIF-2α-enhanced invasiveness of HCC cells. Additionally, the stability and activity of HIF-2α were precisely regulated by TXN via SUMOylation and acetylation, which contributed to HCC metastasis. Our data revealed that the redox protein TXN and HIF-2α are both associated with HCC metastasis, and the fine regulation of TXN on HIF-2α contributes essentially during the process of metastasis. Our study provides new insight into the interaction mechanism between hypoxia and oxidative stress and implies potential therapeutic benefits by targeting both TXN and HIF-2α in the treatment of HCC metastasis.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  HIF-2α; hepatocellular carcinoma; metastasis; thioredoxin

Year:  2020        PMID: 32157720     DOI: 10.1096/fj.202000082R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

Review 1.  Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators.

Authors:  Debasis Mondal; Devin Narwani; Shahnawaz Notta; Dawood Ghaffar; Nikhil Mardhekar; Syed S A Quadri
Journal:  Cancer Drug Resist       Date:  2021-03-19

2.  Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2.

Authors:  Bohan Zhang; Liang Huang; Jiangbo Tu; Tianming Wu
Journal:  Onco Targets Ther       Date:  2020-06-25       Impact factor: 4.147

Review 3.  The crosstalk between HIFs and mitochondrial dysfunctions in cancer development.

Authors:  Xingting Bao; Jinhua Zhang; Guomin Huang; Junfang Yan; Caipeng Xu; Zhihui Dou; Chao Sun; Hong Zhang
Journal:  Cell Death Dis       Date:  2021-02-26       Impact factor: 8.469

4.  HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress.

Authors:  Jian Shi; Zhiyong Xiong; Keshan Wang; Changfei Yuan; Yu Huang; Wen Xiao; Xiangui Meng; Zhixian Chen; Qingyang Lv; Daojia Miao; Huageng Liang; Tianbo Xu; Kairu Xie; Hongmei Yang; Xiaoping Zhang
Journal:  Clin Transl Med       Date:  2021-11

5.  Unveiling Potential Mechanisms of Spatholobi Caulis against Lung Metastasis of Malignant Tumor by Network Pharmacology and Molecular Docking.

Authors:  Feiyu Xie; Mina Wang; Yixin Su; Kunmin Xiao; Xuelei Chu; Sidan Long; Linlu Li; Xin Zhang; Peng Xue; Shijie Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

6.  Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.

Authors:  Feifei Li; Youyang Shi; Xiaojuan Yang; Zhanyang Luo; Guangtao Zhang; Kui Yu; Feng Li; Lixin Chen; Youkang Zhao; Ying Xie; Yuanyuan Wu; Jianfeng Yang; Xiqiu Zhou; Sheng Liu
Journal:  Front Cell Dev Biol       Date:  2022-02-01

Review 7.  Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy.

Authors:  Leah Davis; Matthias Recktenwald; Evan Hutt; Schuyler Fuller; Madison Briggs; Arnav Goel; Nichole Daringer
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

Review 8.  Roles and regulation of histone acetylation in hepatocellular carcinoma.

Authors:  Jin-Kun Xia; Xue-Qian Qin; Lu Zhang; Shu-Jun Liu; Xiao-Lei Shi; Hao-Zhen Ren
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

9.  Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.

Authors:  Carolina Méndez-Blanco; Paula Fernández-Palanca; Flavia Fondevila; Javier González-Gallego; José L Mauriz
Journal:  Ther Adv Med Oncol       Date:  2021-02-07       Impact factor: 8.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.